CHICAGO – Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the opening of its MÜV™ Dispensary located at 8103 Vineland Ave., Orlando, Florida, which is scheduled to open June 4, 2021 at 10:00am.
Verano’s 34th MÜV Dispensary in Florida is conveniently located just off Interstate 4 and International Drive near Orlando’s world-famous theme parks, studios, and attractions. The new MÜV storefront is situated directly across the street from the Orlando Vineland Premium Outlets. Florida patients visiting the area will now have convenient access to medical cannabis as they enjoy the surrounding shopping and attractions.
“Orlando gets 65 million visitors every year and we’re confident this location will be popular with both tourists and residents, who are Florida medical cannabis patients. With our dispensary at the corner of Vineland and International Drive, the visibility and accessibility are exceptional,” said John Tipton, President of Verano. “We’re confident our wide range of award-winning products and attentive patient care will be a welcome addition to this community.”
The newest state-of-the-art MÜV Dispensary will offer an extensive selection of award-winning products including MÜV Wana Soft Chew edibles, chocolates and lozenges, flower, pre-rolls, a wide range of vaporizer pens, metered-dose inhalers, topicals and oral sprays; along with patented encapsulation formulations in its EnCaps™ capsules, tinctures, 72-hour transdermal patches and transdermal gels. MÜV also has one of the widest selections of concentrates for patients requesting macro-dosing options.
Patients are encouraged to order at muvfl.com for express pickup or delivery. For more information about the new ADA-compliant Orlando MÜV Medical Cannabis Dispensary, including hours and available MÜV products, visit muvfl.com.
Verano Holdings Inc. is a leading, vertically-integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands: Verano™, Avexia™, Encore™, and MÜV™. The company’s portfolio encompasses 14 U.S. States, with active operations in 11, which includes nine production facilities comprising approximately 770,000 square feet of cultivation. Verano designs, builds, and operates dispensaries under retail brands Zen Leaf™ and MÜV, focused on delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at verano.com.
Through continual research and development, the MÜV™ brand of medical cannabis infused products has received multiple patents for its award-winning MÜV products line that provides quality, consistent and reliable medical cannabis therapies to patients. Patients are encouraged to place reservations online at muvfl.com for in-store pickup, order for delivery, or visit any MÜV Dispensary for alternative medical cannabis medicine you can trust.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements include, but are not limited to statements or information with respect to the benefits of DTC eligibility, the Company’s position in the marketplace, the proposed completion or buildout of Company facilities, the Company’s cultivation capacity, the completion of pending acquisitions, the accretive nature of acquisitions, the fortification of the Company’s presence in core markets, the possibility of material organic expansion, delivery of shareholder value and the ability to maintain industry-leading margins and add depth to leadership.
Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements, including, without limitation, the risk factors discussed in the Company’s filings on SEDAR at www.sedar.com.
The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.